Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 12:24 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2497–2520 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Pediatric Sleep Disordered Breathing, Obstructive Sleep Apnea
Interventions: WatchPAT 400; Device
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 6 Years to 18 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Hummelstown, Pennsylvania

Conditions: Breast Cancer, Melanoma
Interventions: Multispectral Optoacoustic Tomography Imaging; Diagnostic Test
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: Montvale, New Jersey • Commack, New York • New York, New York

Conditions: Atherosclerosis, Heart Diseases, Coronary, Coronary Artery Disease, Cardiovascular Diseases
Interventions: SYNERGY 4.50 mm and 5.0 mm Coronary Stent System; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 9
States / cities: New Haven, Connecticut • Clearwater, Florida • Boston, Massachusetts + 6 more

Conditions: Medical Device Complication, Brain Injuries, Brain Diseases, Stroke, Vasospasm
Interventions: conventional transcranial Doppler probe and wearable ultrasound patch.; Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Diego, California

Conditions: Chronic Non-malignant Pain
Interventions: Buprenorphine transdermal patch, Placebo to match BTDS; Drug
Lead sponsor: Purdue Pharma LP; Industry
Eligibility: 18 Years and older
Enrollment: 267 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001
U.S. locations: 21
States / cities: Phoenix, Arizona • Trumbull, Connecticut • Clearwater, Florida + 17 more

Conditions: Metastatic Renal Cell Carcinoma, Metastatic Urothelial Carcinoma
Interventions: Nivolumab, Atezolizumab, Radiation & immunotherapy, Pembrolizumab; Drug · Radiation
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 19 Years to 90 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Actinic Keratosis
Interventions: SOR007 (Uncoated Nanoparticulate Paclitaxel) Ointment, SOR007 Ointment Vehicle; Drug · Other
Lead sponsor: DFB Soria, LLC; Industry
Eligibility: 45 Years to 85 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Malignant Solid Neoplasm, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7
Interventions: 3-Dimensional Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy, Laboratory Biomarker Analysis, Pembrolizumab, Proton Beam Radiation Therapy, Radiation Therapy, Stereotactic Body Radiation Therapy; Radiation · Other · Biological
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Coronary; Ischemic
Interventions: Volcano Verrata Pressure Wire, St. Jude Medical (SJM) Aeris Pressure Wire System; Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Localized Intermediate Risk Prostate Lesions
Interventions: ExAblate MR Guided Focused Ultrasound; Device
Lead sponsor: InSightec; Industry
Eligibility: 50 Years and older · Male only
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2021
U.S. locations: 9
States / cities: Duarte, California • Los Angeles, California • Stanford, California + 5 more

Conditions: Skin Lesion, Melanoma (Skin), Mole
Interventions: Diagnostic Test; Other
Lead sponsor: Orlucent, Inc; Industry
Eligibility: 21 Years and older
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 6
States / cities: Fremont, California • Irvine, California • Menlo Park, California + 3 more

Conditions: Cutaneous Tumor, Malignant Solid Tumor
Interventions: JCXH-211; Drug
Lead sponsor: Immorna Biotherapeutics, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cutaneous Lupus
Interventions: 532nm laser, 1064nm laser, Topical corticosteroid; Device · Drug
Lead sponsor: David Weinstein; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemias, Multiple Myeloma With Plasmacytoma
Interventions: Single fraction radiation, Donor Lymphocyte Infusion (DLI), Apheresis; Procedure · Biological
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 75 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Sarcoma, Soft Tissue
Interventions: Pembrolizumab, Radiation therapy; Drug · Radiation
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Orange, California

Conditions: Fluid Intake in Athletes, Sweating Rate in Athletes, Sweat Chloride Concentration in Athletes
Interventions: Smart Cap, running and fitness exercisers only, Sweat Patch, all subjects- running, fitness, cycling, Reference sweat patch, all subjects - running, fitness, cycling, Bottle Scale, all subjects - running, fitness, cycling; Device · Other
Lead sponsor: PepsiCo Global R&D; Industry
Eligibility: 16 Years to 65 Years
Enrollment: 173 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 3
States / cities: Barrington, Illinois • Chicago, Illinois • Deer Park, Illinois

Conditions: Hepatocellular Carcinoma
Interventions: ThermoDox, Dummy infusion; Drug
Lead sponsor: Imunon; Industry
Eligibility: 18 Years and older
Enrollment: 554 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Non-Melanoma Skin Cancers
Interventions: SM-020 1% Gel; Drug
Lead sponsor: DermBiont, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma
Interventions: Prednisone, Vincristine, Daunorubicin, Pegaspargase, Erwinase®, Cyclophosphamide, Cytarabine, Mercaptopurine, Dasatinib, Methotrexate, Blinatumomab, Ruxolitinib, Bortezomib, Dexamethasone, Doxorubicin, Etoposide, Clofarabine, Vorinostat, Idarubicin, Nelarabine, Thioguanine, Asparaginase Erwinia chrysanthemi (recombinant)-rywn, Calaspargase Pegol; Drug
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 1 Year to 18 Years
Enrollment: 790 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 7
States / cities: Palo Alto, California • San Diego, California • Peoria, Illinois + 4 more

Conditions: Smoking Cessation, Motivation
Interventions: Phoenix, NRT order button, Factoid; Behavioral
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years and older
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Coronary Artery Disease
Interventions: 4.0 CYPHER Sirolimus-Eluting Coronary Stent; Device
Lead sponsor: Cordis US Corp.; Industry
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Enamel Caries
Interventions: Experimental Toothpaste containing 1450ppm SMFP, Toothpaste containing 1450ppm SMFP, Toothpaste with no fluoride; Other
Lead sponsor: Unilever R&D; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Pigmented Lesions, Pigmented Skin Lesion, Pigmented Moles, Skin Lesion
Interventions: SECM Skin Imaging; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Abortion in First Trimester
Interventions: Acupressure with Beads, Acupuncture with Needles, Placebo Adhesive Disks; Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 177 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Pediatric/Adolescent WatchPAT 400 Reliability Pilot Study

A Study of Tumor Imaging With Multispectral Optoacoustic Tomography

A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)

Transcranial Doppler Using Wearable Ultrasound Patch

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain

A Phase II Randomized Trial of Immunotherapy Plus Radiotherapy in Metastatic Genitourinary Cancers

Study of SOR007 Ointment for Actinic Keratosis

Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Novel Adenosine-independent Index of Coronary Artery Stenosis Severity Resting Flow Reserve

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions

Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging)

Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors

Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids Alone

Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation

Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma

Validity of Smart Cap and Smart Sweat Patch

Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)

A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers

Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma

Project Phoenix: Pilot Intervention for Smokers Who Are Not Ready to Quit Smoking

Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Evaluation of Efficacy of Sodium Monofluorophosphate (SMPF) Toothpastes on Enamel Lesion Remineralisation

Pilot Study of Imaging Human Skin With High-Speed Spectrally Encoded Confocal Microscopy

Auriculotherapy - Pain Management of Aspiration Abortion